⚠ An Exclusive Service Monopoly Is a Regulatory TargetLow threat

Intuitive Surgical (ISRG) — threat to the moat

Hospitals paying one supplier to maintain equipment they own is precisely what right-to-repair rules address.

Intuitive services its own systems and no one else does. That is normal for complex surgical robotics, it is defensible on safety grounds, and it produces $1,572.1 million of high-margin revenue from equipment hospitals have already bought1.

The service position$1,572.1Mservice revenue, 2025$1.6Mwhat the hospitalpaid for the machineOnecompanies permittedto maintain itService grew 20% against 12% installed-base growth.
Defensible on safety grounds, and exactly the fact pattern medical right-to-repair proposals are written about.

It is also the fact pattern that medical right-to-repair proposals are aimed at. The argument on the other side is that a hospital that owns a $1.6 million machine should be able to choose who maintains it, and that exclusive service arrangements raise costs without improving outcomes. The argument for the status quo is that a mis-serviced surgical robot injures a patient and that the manufacturer holds the design history, the validated procedures and the liability.

There is an adjacent exposure that has already produced disclosures rather than debate. Medical device companies carry obligations to correct or remove devices in the field, and Intuitive devotes a section of its filings to field actions, recalls and corrections, noting that these "can result in adverse effects on our business, including damage to our reputation, delays by customers of purchase decisions, reduction or stoppage of the use of installed systems, and reduced revenue as well as increased expenses"2. The service organisation is also the recall organisation.

Neither risk is near-term and neither is trivially dismissed. What would signal a change is a service-revenue growth rate that decouples from installed-base growth — 20% against 12% in 20253 is the mix effect; 12% against 12% would mean the pricing power in renewals had gone.

References
  1. ReportedThat is normal for complex surgical robotics, it is defensible on safety grounds, and it produces $1,572.1 million of high-margin revenue from equipment hospitals have already bought.
    Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 7 MD&A, results of operations (instruments and accessories $6,018.9M, systems $2,473.7M, service $1,572.1M, recurring revenue $8,465.3M, gross margin 66.0%, operating income $2,945.5M, average selling price, lease revenue recognition, and the discussion of procedure categories) — FY2025 · publ. February 3, 2026 · source ↗
  2. ReportedMedical device companies carry obligations to correct or remove devices in the field, and Intuitive devotes a section of its filings to field actions, recalls and corrections, noting that these "can result in adverse effects on our...
    Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 7 MD&A, business and operating highlights (3,153,000 da Vinci procedures up 18%, 1,721 placements, an installed base of 11,106, utilisation up about 3%, 870 da Vinci 5 placements, Ion procedures and placements, procedures by region and category, and revenue denominated in foreign currencies) — FY2025 · publ. February 3, 2026 · source ↗
  3. ReportedWhat would signal a change is a service-revenue growth rate that decouples from installed-base growth — 20% against 12% in 2025 is the mix effect; 12% against 12% would mean the pricing power in renewals had gone.
    Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 7 MD&A, business and operating highlights (3,153,000 da Vinci procedures up 18%, 1,721 placements, an installed base of 11,106, utilisation up about 3%, 870 da Vinci 5 placements, Ion procedures and placements, procedures by region and category, and revenue denominated in foreign currencies) — FY2025 · publ. February 3, 2026 · source ↗
Sources
Generated September 23, 2026